168 related articles for article (PubMed ID: 38573819)
1. STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
Elife; 2024 Apr; 13():. PubMed ID: 38573819
[TBL] [Abstract][Full Text] [Related]
2. STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
bioRxiv; 2023 Sep; ():. PubMed ID: 37732258
[TBL] [Abstract][Full Text] [Related]
3. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
4. Snail cooperates with KrasG12D to promote pancreatic fibrosis.
Shields MA; Ebine K; Sahai V; Kumar K; Siddiqui K; Hwang RF; Grippo PJ; Munshi HG
Mol Cancer Res; 2013 Sep; 11(9):1078-87. PubMed ID: 23761168
[TBL] [Abstract][Full Text] [Related]
5. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.
Mills LD; Zhang Y; Marler RJ; Herreros-Villanueva M; Zhang L; Almada LL; Couch F; Wetmore C; Pasca di Magliano M; Fernandez-Zapico ME
J Biol Chem; 2013 Apr; 288(17):11786-94. PubMed ID: 23482563
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic Acid Inhibits
Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
[TBL] [Abstract][Full Text] [Related]
7. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
Laklai H; Miroshnikova YA; Pickup MW; Collisson EA; Kim GE; Barrett AS; Hill RC; Lakins JN; Schlaepfer DD; Mouw JK; LeBleu VS; Roy N; Novitskiy SV; Johansen JS; Poli V; Kalluri R; Iacobuzio-Donahue CA; Wood LD; Hebrok M; Hansen K; Moses HL; Weaver VM
Nat Med; 2016 May; 22(5):497-505. PubMed ID: 27089513
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.
Baumgart S; Chen NM; Siveke JT; König A; Zhang JS; Singh SK; Wolf E; Bartkuhn M; Esposito I; Heßmann E; Reinecke J; Nikorowitsch J; Brunner M; Singh G; Fernandez-Zapico ME; Smyrk T; Bamlet WR; Eilers M; Neesse A; Gress TM; Billadeau DD; Tuveson D; Urrutia R; Ellenrieder V
Cancer Discov; 2014 Jun; 4(6):688-701. PubMed ID: 24694735
[TBL] [Abstract][Full Text] [Related]
9. STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis.
D'Amico S; Shi J; Martin BL; Crawford HC; Petrenko O; Reich NC
Genes Dev; 2018 Sep; 32(17-18):1175-1187. PubMed ID: 30135074
[TBL] [Abstract][Full Text] [Related]
10. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
11. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
12. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
14. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
15. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Kim H; Choi JA; Kim JH
J Biol Chem; 2014 Aug; 289(32):22151-60. PubMed ID: 24990945
[TBL] [Abstract][Full Text] [Related]
16. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells.
Bailey JM; Hendley AM; Lafaro KJ; Pruski MA; Jones NC; Alsina J; Younes M; Maitra A; McAllister F; Iacobuzio-Donahue CA; Leach SD
Oncogene; 2016 Aug; 35(32):4282-8. PubMed ID: 26592447
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
Sato K; Hikita H; Myojin Y; Fukumoto K; Murai K; Sakane S; Tamura T; Yamai T; Nozaki Y; Yoshioka T; Kodama T; Shigekawa M; Sakamori R; Tatsumi T; Takehara T
PLoS One; 2020; 15(7):e0235573. PubMed ID: 32609742
[TBL] [Abstract][Full Text] [Related]
19. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
[TBL] [Abstract][Full Text] [Related]
20. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
Maier HJ; Wagner M; Schips TG; Salem HH; Baumann B; Wirth T
Oncogene; 2013 May; 32(21):2690-5. PubMed ID: 22751123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
